Related Experiment Video
Updated: Dec 23, 2025

Viral Transgene Expression in Rodent Hearts and the Assessment of Cardiac Arrhythmia Risk
Published on: July 27, 2022
Gene therapy for inherited arrhythmias
Vassilios J Bezzerides1, Maksymilian Prondzynski1, Lucie Carrier2,3
1Department of Cardiology, Boston Children's Hospital, 300 Longwood Ave, Boston, MA 02115, USA.
Gene therapy offers a promising new avenue for treating inherited arrhythmias, which carry a lifelong risk of sudden death. Research is exploring these targeted treatments for conditions like catecholaminergic polymorphic ventricular tachycardia and hypertrophic cardiomyopathy.
Area of Science:
- Cardiology
- Genetics
- Molecular Biology
Background:
- Inherited arrhythmias are genetic disorders increasing sudden death risk.
- Current therapies are insufficient and do not halt disease progression.
- Gene mutations can affect electrophysiology, cardiac structure, or both.
Purpose of the Study:
- To provide an overview of gene therapy strategies for inherited arrhythmias.
- To review recent gene therapy studies for specific conditions.
Main Methods:
- Literature review of gene therapy approaches.
- Focus on studies for catecholaminergic polymorphic ventricular tachycardia and MYBPC3-related hypertrophic cardiomyopathy.
Main Results:
- Gene therapies show potential for molecularly targeted treatment of inherited arrhythmias.
- Specific examples include catecholaminergic polymorphic ventricular tachycardia and hypertrophic cardiomyopathy.
Conclusions:
- Gene therapy presents a potent, targeted option for managing inherited arrhythmias.
- Further research is crucial for developing effective gene-based treatments.
Related Concept Videos
Mechanism of Cardiac Arrhythmias
Heart Failure Drugs: Inotropic Agents
Dysrhythmias VI: Management of Dysrhythmias
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Gene Therapy

